TY - JOUR
T1 - Outbreak of COVID-19 infection in children
T2 - Fear and serenity
AU - Pavone, P.
AU - Ceccarelli, M.
AU - Taibi, R.
AU - Rocca, G. L.A.
AU - Nunnari, G.
N1 - Funding Information:
The authors thank European Review for Medical and Pharmacological Sciences for allowing the quick publication of this article without a fee.
Publisher Copyright:
© 2020 Verduci Editore s.r.l. All rights reserved.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020
Y1 - 2020
N2 - OBJECTIVE: The recent outbreak of SARS-CoV-2 greatly involves the resources of the global healthcare system, as it affects newborns, adults, and elders. This infection runs in three major stages: a mild cold-like illness, a moderate respiratory syndrome and a severe acute interstitial pneumonia. SARS-CoV-2 infection seems to have a more benign evolution in children. As a matter of fact, low susceptibility and minor aggressivity have been highlighted in most cases. There are currently no effective antiviral drugs treatment for the affected children. No sufficient results have been reached by the use of interferon (IFN), lopinavir/ritonavir, orbidol, and oseltamivir in the treatment of the coronaviruses infection. The aim of this short review is to highlight the differences existing between COVID-19 cases in adults and children.
AB - OBJECTIVE: The recent outbreak of SARS-CoV-2 greatly involves the resources of the global healthcare system, as it affects newborns, adults, and elders. This infection runs in three major stages: a mild cold-like illness, a moderate respiratory syndrome and a severe acute interstitial pneumonia. SARS-CoV-2 infection seems to have a more benign evolution in children. As a matter of fact, low susceptibility and minor aggressivity have been highlighted in most cases. There are currently no effective antiviral drugs treatment for the affected children. No sufficient results have been reached by the use of interferon (IFN), lopinavir/ritonavir, orbidol, and oseltamivir in the treatment of the coronaviruses infection. The aim of this short review is to highlight the differences existing between COVID-19 cases in adults and children.
KW - Children
KW - COVID-19
KW - SARS-CoV-2
UR - http://www.scopus.com/inward/record.url?scp=85084277366&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084277366&partnerID=8YFLogxK
U2 - 10.26355/eurrev_202004_21043
DO - 10.26355/eurrev_202004_21043
M3 - Article
VL - 24
SP - 4572
EP - 4575
JO - European Review for Medical and Pharmacological Sciences
JF - European Review for Medical and Pharmacological Sciences
SN - 1128-3602
IS - 8
ER -